| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/15/2008 | WO2008058098A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008056156A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | WO2008056119A1 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use |
| 05/15/2008 | WO2008056118A1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use |
| 05/15/2008 | WO2005086954A3 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 05/15/2008 | US20080114055 By using [3-(3,4-Dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethyl-ammonium chloride to reduce or reverse cachexia or disease-induced body weight loss |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114043 Medicinal Composition for Inhalation |
| 05/15/2008 | US20080114030 Diarymethyl and related compounds |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080114003 Pyrimidinylisoxazole Derivatives |
| 05/15/2008 | US20080114002 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid |
| 05/15/2008 | US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113956 Substituted Porphyrins |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113909 Compositions and Methods for Treating Stat-6 Associated Diseases or Conditions |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080112983 Barn Dust Extract Providing Protection From Allergies |
| 05/15/2008 | CA2669038A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 05/15/2008 | CA2668645A1 Method of treating asthma, allergic rhinitis, and skin disorders |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1920783A1 Recombinant RSV virus expression systems and vaccines |
| 05/14/2008 | EP1920763A1 Pharmaceutical compositions for inhalation |
| 05/14/2008 | EP1919914A2 P38 map kinase inhibitors and methods for using the same |
| 05/14/2008 | EP1919884A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
| 05/14/2008 | EP1919484A1 Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure |
| 05/14/2008 | EP1553943B1 Use of tenatoprazole for the treatment of gastroesophageal reflux |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 05/14/2008 | CN101180276A 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 05/14/2008 | CN101180059A Combination of indacaterol derivates for curing air flue disease and other matters |
| 05/14/2008 | CN101180058A Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases |
| 05/14/2008 | CN101176783A Walnut ginger pellet and preparation method thereof |
| 05/14/2008 | CN101176765A Chinese medicine detoxication preparations and preparation method thereof |
| 05/14/2008 | CN101176761A Atmosphere regulating cream special for children |
| 05/14/2008 | CN101176752A Chinese medicine preparation method and composition for curing COPD |
| 05/14/2008 | CN101176742A Pharmaceutical composition for curing cough |
| 05/14/2008 | CN101176740A Method for extracting angelica essential oil |
| 05/14/2008 | CN101176737A Pharmaceutical composition of chicken bile and preparation thereof |
| 05/14/2008 | CN101176731A Application of asiatic acid in the aspect of resisting pulmonary fibrosis |
| 05/14/2008 | CN101176730A Pharmaceutical composition and technique of preparing the same |
| 05/14/2008 | CN100387598C Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/14/2008 | CN100387597C Amide substituted imidazopyridines |
| 05/14/2008 | CN100387280C Phlegm transforming Chinese medicinal formulation for children and its preparation method |
| 05/14/2008 | CN100387269C Schisandra chinensis soft capsule |
| 05/14/2008 | CN100387262C Hedyotis herba powder injection |
| 05/14/2008 | CN100387249C Traditional Chinese medicine formulation for treating ulcer |
| 05/14/2008 | CN100387234C Medicine containing forrest silk vine root orherb aglycone, and its preparing method and use |
| 05/14/2008 | CN100387221C Preparation method of Chinese mugwort injection |
| 05/14/2008 | CN100387160C Cigarette-like smoking substitute for women use |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371747 Cyanoalkylamino derivatives as protease inhibitors |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2310222C New composition of matter |
| 05/08/2008 | WO2008053942A1 Composition for throat |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053444A2 Treating a respiratory condition with bifidobacterium |
| 05/08/2008 | WO2008053199A1 Combination therapy for the treatment of respiratory diseases |
| 05/08/2008 | WO2008036308A3 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith |
| 05/08/2008 | WO2008028935A3 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents |
| 05/08/2008 | WO2007146138A3 Thiadiazole compounds and methods of use thereof |
| 05/08/2008 | WO2007129226A3 Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders |
| 05/08/2008 | US20080108809 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/08/2008 | US20080108699 Composition Comprising Dihomo-y-Linolenic Acid (Dgla) As Active Ingredient |
| 05/08/2008 | US20080108695 5,6,7-trihydroxyheptanoic acid and its analogs ; allergic dermatitis, contact hypersensitivity, urticaria (hives), rosacea, or psoriasis |
| 05/08/2008 | US20080108676 Benzothiazolecarboxamides |
| 05/08/2008 | US20080108654 Protein kinase inhibitors; antitumor agents; such as 5-methyl-1-quinol-4-ylmethyl-3-(4-trifluoromethanesulfonylphenyl)imidazolidine-2,4-dione trifluoroacetate |
| 05/08/2008 | US20080108615 such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; anticarcinogenic agents, neurodegenerative diseases, brain disorders, stroke, antischemic agent |
| 05/08/2008 | US20080108592 treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | US20080107757 Sophorae Subprostratae Radix Extract for Prevention and Treatment of Respiratory Diseases |
| 05/08/2008 | US20080107740 Dry powder inhaler; metered dose nebulization; asthma or other inflammatory respiratory disorders; correct molecular ratio of salmeterol active in the lung while budesonide active in the lung can be ensured |
| 05/08/2008 | US20080107730 Sustained release pharmaceutical preparations and methods for producing the same |
| 05/08/2008 | US20080107723 Methods of Treating Pulmonary Distress |
| 05/08/2008 | US20080107634 Using mix comprising bifidobacterium and lactobacillus as tool in treatment of gastrointestinal and influenzal disorders |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107609 Administering mometasone furoate and lactose particles from a multidose dry powder inhaler in daily doses of 800 mu g where at least about 250 mu g of the particles have sizes equal to or less than about 6.5 mu m. |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1725553B1 Tetrahydropyridoindole derivatives |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1395269B1 Lipoteichoic acid from lactic acid bacteria for use as medicament and in the treatment of bacterial diseases |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |